Results from the Annual and Special Meeting of Shareholders
MONTREAL, QUEBEC -- (Marketwired) -- 08/24/16 -- EXPLORATION KHALKOS. ("Khalkos") (TSX VENTURE: KAS) announces that all the resolutions that were presented at the annual and special meeting on August 23, were approved by the shareholders. These resolutions include the nomination of the directors and the auditors as well as the Stock Option Plan.
Shareholders elected Robert Gagnon, Jean-Paul Lacasse, Dominique Doucet, Roger Doucet and Nicolas Cantin to the Board of Directors. Moreover, during its board meeting, held after the meeting, Ms. Eliane Tremblay Paradis was elected as Secretary and Chief Financial Officer of the Company, Robert Gagnon as President, Chief Executive Officer and Dominique Doucet as Chairman of the Board. Jean-Paul Lacasse, Nicolas Cantin and Dominique Doucet will form the audit committee. Mr. Lacasse will serve as the president of the committee.
The Board of Directors has granted 1 150 000 stock options under its Stock Option Incentive Plan to directors, officers, consultants and employees at an exercise price of $0.16 per share. The options expire five (5) years from the date of grant.
Khalkos will benefit from the valuable geological expertise on Malartic and Bousquet mining camps from its new director, Roger Doucet. He participated in the past to several significant auriferous discoveries in these camps.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts: Robert Gagnon President (819) 825-2303 [email protected] www.khalkos.com Christian Guilbaud Corporate Development (514) 813-7862 [email protected] (514) 510-7964 (FAX)
Source: Khalkos Exploration Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Federal Home Loan Bank of New York Announces First Quarter 2024 Operating Highlights
- InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Reports Positive PH15 Data from Pilot Study Showing Psychomotor Impairment Improvement
- Ariento Expands Microsoft Relationship, Adds AOS-G Partnership
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!